Lipocine (NASDAQ:LPCN) Lowered to “Hold” at StockNews.com
Lipocine (NASDAQ:LPCN – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Saturday. Lipocine Price Performance Shares of Lipocine stock opened at $3.70 on Friday. The business has a 50-day simple moving average of $6.61 and a 200 day simple moving average […]
More Stories
Order of the Sinking Star is Ready to Launch on PlayStation 5 and TV
The creator of Braid and The Witness, Jonathan Blow, is returning with an all-new puzzle video game, Order of the...
Netflix’s Upcoming Drama, All the Truth in My Lies: Release Date, Cast, and More
Excited to know about the upcoming Spanish drama on Netflix, All the Truth in My Lies. If you love watching...
Obsession (2026): Release Date, Cast Members, Trailer, Plot, and More
Be Alert: Spoilers Ahead! Are you also a lover of horror shows and looking for upcoming horror movies and series...
Desire 2026: Release Date, Cast Members, Trailer, Audio, and More
Netflix is expanding its international movie lineup with intense action, thriller, and drama that explore the complexities of human emotions....
AI Assistants Overwhelmingly Cite Third-Party Lists, Not Company Homepages, Study Finds
Artificial intelligence assistants overwhelmingly cite third-party “best-of” and comparison pages rather than companies’ own websites, according to a new study...
How Businesses are Incorporating AI Video Into Sales Processes
Over the last few years, businesses have had to rethink their traditional sales processes. Consumers are more empowered to complete...